In conclusion, gastric carcinoma appears, from the biological point of view, as a heterogeneous disease that implies numerous genetic and epigenetic alterations, such as E-cadherin (CDH1) gene specific mutations, mutations of the gene at the level of p53 protein [18]. Here, CDH1 is linked to gastric carcinoma.